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ABSTRACT 
OPIOID USE IN THE CESAREAN SECTION PATIENT WITH THE 
PREOPERATIVE ADMINISTRATION OF INTRAVENOUS ACETAMINOPHEN 
by Dana Edwards Bernardo 
December 2016 
Cesarean sections are one of the most common surgical procedures and there are 
no current guidelines for the management of postoperative pain control (Darvish, 
Ardestani, Shali, & Tajik, 2013).  Unresolved pain in this population can lead to long 
lasting problems, such as chronic pain and depression (Booth, Harris, Eisenach, & Pan, 
2015).  The goal of multimodal therapy with IV acetaminophen for CS mothers was to 
ensure a rapid and safe recovery process with reduced adverse complications and 
shortened hospital length of stay.  The independent t-test was used to compare the mean 
time for length of stay, first request of pain medication, and total morphine equivalents 
needed 24-hours and 48-hours post-cesarean section between the treatment group, Group 
A and control group, Group C. 
The results reflected that the preoperative administration of IV acetaminophen 
reveal that Group A had a shorter length of stay than Group C.  The difference was 
statistically significantly different (p = 0.022).  The amount of time for first request of 
pain medication was compared.  Group A had a shorter length of time for first request of 
pain medication compared to Group C.  The difference was not statistically significantly 
different (p =0.299) indicating Group C had a longer time for opioid/analgesic 
intervention compared to Group A.  Morphine milligram equivalents (MME) were 
compared between the two groups between 24 and 48 hours.  The mean MME for Group 
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A and Group C was not statistically significantly different (p = 0.299) indicating there 
was no difference in MME between the two groups.  The MME of 48 hours was higher in 
Group A than Group C and this difference was statistically significantly different (p = 
0.002) indicating that those who did not receive preoperative administration of IV 
acetaminophen had a lower MME consumption. 
Keywords:  Ofirmev, paracetamol, intravenous acetaminophen, cesarean sections, 
postoperative pain control, multimodal analgesia 
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CHAPTER I – INTRODUCTION 
Surgical pain experienced by any patient can be challenging for caregivers to 
regulate effectively.  Managing postoperative pain for the cesarean section (CS) patient is 
different from other surgical procedures (Cancado, Omais, Ashmawi, & Torres, 2012).  
Treatment of acute pain for the CS mother should be fast and safe in order to effectively 
take care of the newborn (Cancado et al., 2012).  If acute pain is not managed properly 
for CS mothers, unresolved pain can lead to chronic pain for 10-15% of mothers 
(Orbach-Zinger et al., 2014).  The development of postpartum depression and post-
traumatic stress disorder can also occur while enduring acute pain during childbirth 
(Orbach-Zinger et al., 2014).  In addition to decreased comfort, acute pain can cause 
many adverse complications by stimulating the sympathetic nervous system (SNS), 
leading to tachycardia, hypertension, and arrhythmias (Nagelhout & Plaus, 2014).  
Unrelieved pain has been linked to metabolic disturbances by interfering with the 
endocrine system, impairing cognitive function, depressing the immune system, and 
inducing high anxiety states, which in turn affects digestion, heart rate, breathing and 
other key bodily functions (Nagelhout & Plaus, 2014). 
Background 
Cesarean sections are increasing every year and there is concern for maternal 
health relating to this type of delivery (Cancado et al., 2012).  The common complaint for 
these patients is postoperative pain (Orbach-Zinger et al., 2014).  These patients present 
with distinct challenges with the use of opioids. In addition to the aforementioned 
problems to which pain can contribute to, other impairments found in the cesarean patient 
related to the use of opioids are decreased alertness and stamina needed 
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to take care of and breastfeed their newborn child (Ismail, Shahzad, & Shafiq, 
2012).  Instead of utilizing opioids only, a multimodal approach should be implemented 
when treating postoperative pain for cesarean deliveries (Valentine, Carvalho, Lazo, & 
Riley, 2015). 
The American Society of Anesthesiologists Task Force on Acute Pain urges 
multimodal pain control methods unless contraindicated (Nishimoto, 2014).  Multimodal 
analgesia involves the combination of opioids along with nonopioid analgesics or NOPAs 
(Pogatzki-Zahn, Chandrasena, & Schug, 2014).  Most commonly, NOPAs are 
recommended as the choice agent and opioids are to be used as supplemental agents.  The 
NOPAs’ efficacy and safety should not be a concern and should provide favorable results 
for pain control (Pogatzki-Zahn et al., 2014).  Incorporating a multimodal approach to 
reducing acute pain and promoting comfort may help avert the long-term effects of 
chronic pain and depression that occur in CS patients (Booth, Harris, Eisenach, & Pan, 
2015). 
Significance 
Postoperative pain negatively affects the patient’s quality of life.  Adverse effects 
of improper pain management by the anesthesia provider before and during surgery can 
lead to physical and emotional complications postoperatively (Pasero & Stannard, 2012).  
Ambulation can be delayed which can lead to venous thromboembolism, rehabilitation 
can be shortened or missed, depression and anxiety may develop, and hospital 
readmissions can occur (Pasero & Stannard, 2012).  These compounded problems can 
lead to decreased patient satisfaction (Cancado et al., 2012).  Therefore, pain 
management should be a primary concern for the anesthesia provider.  The goal of the 
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anesthesia provider is to provide the safest and the best pain control methods to enable 
the safest and easiest recovery possible. 
Clinical Question 
Does the use of preoperative administration of IV acetaminophen decrease the use 
of opioids compared to those who do not receive IV acetaminophen by women who have 
given birth by CS?  Cesarean section is one of the most common procedures in the field 
of obstetric/gynecologic (OB/GYN), yet there are no guidelines for treating post-cesarean 
pain (Darvish et al., 2013). 
Hamilton and colleagues (2015) reveal that of the 51.4 million surgical 
procedures that take place annually in the United States alone, approximately 1.3 million 
of these surgical procedures are CS.  Frequency of cesarean sections surgeries is second 
only to arteriography and angiocardiography (Hamilton et al., 2015).  Because long 
lasting effects can arise from insufficient analgesia, an alternative approach for post CS 
pain is indicated.  An estimated 30%-40% of CS patients experience moderate to severe 
pain postoperatively, which can lead to fear, anxiety, and depression (Ayatollahi, Faghihi, 
Behdad, Heiranizadeh, & Baghianimoghadam, 2014).  When CS pain is managed 
appropriately ensuring a safe and rapid recovery, a CS mother could have more favorable 
results from breastfeeding and bonding experiences with her child (Niklasson, Arnelo, 
Ohman, Segerdahl, & Blanck, 2015).  
Problem Statement 
In the United States, cesarean section (CS) accounts for more than 25% of all 
deliveries (Kessous, et al. 2012).  There is a marked increase in CS that can be attributed 
to legal issues within the obstetrics/gynecological (OB/GYN) departments, as well as an 
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increase in the number of mothers, that due to their age or their socioeconomic class, are 
considered high-risk (Darvish et al., 2013).  With the dramatic increase in cesarean 
deliveries performed each year, the management of postoperative pain and other 
complications is becoming more relevant than ever before (Darvish et al., 2013).  
Insufficient analgesia can create long-term problems; in contrast, the safe, 
uncomplicated, and rapid recovery CS mothers receive via multimodal treatment can help 
reduce adverse complications, shorten the hospital stay, and improve breastfeeding, 
which leads to quality bonding between a mother and her child (Niklasson et al., 2015).  
Also, effective management of the acute surgical pain experience in CS patients can help 
prevent future problems with chronic pain and depression (Booth et al., 2015). 
Purpose of the Project 
The purpose of this doctoral project is to foster a change in clinical practice for 
the management of postoperative pain for CS patients.  The use of a multimodal approach 
with nonopioids, such as IV acetaminophen and opioids as a supplement for break 
through pain, is becoming increasingly commonplace in many surgical procedures 
(Lachiewicz, 2013).  This study explored the impact of preoperative administration of IV 
acetaminophen and determined if the administration reduced the mean time for length of 
stay, first request of pain medication, and the total morphine equivalents needed 24-hours 
and 48-hours post-cesarean delivery when compared to those who did not receive IV 
acetaminophen prior to CS.   
Length of stay was calculated in hours beginning with anesthesia start time and 
ended when the patient was discharged from the hospital.  The time of first request of 
pain medication was calculated in minutes and hours starting with the anesthesia time 
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until the patient first asked for pain medication.  Total morphine milligram equivalents 
were calculated by totaling the analgesics given in a 24-hour and 48-hour time period. 
Acetaminophen History and Trade Names 
For over a century acetaminophen has been used as a safe and effective 
medication for analgesia, as well as an antipyretic in both oral and rectal suppository 
forms (Pasero & Stannard, 2012).  It was first synthesized in 1878, with clinical use 
starting worldwide the following year; however, it was not until the 1950s that 
acetaminophen was sold in the United States (Pasero & Stannard, 2012).  Since then, it 
has become one of the most conventional and best known medications for the treatment 
of fever and mild to moderate pain for children and adults (Pasero & Stannard, 2012). 
Ofirmev®, also known as paracetmol in Europe, is the intravenous version of 
acetaminophen.  In 2001, paracetamol was manufactured by Cadence Pharmaceuticals 
and was available for use in over 80 countries, excluding the United States (Buck, 2011).  
The Food and Drug Administration (FDA) granted permission on November 2, 2010, for 
the use IV of Ofirmev®, in the United States (Buck, 2011).  The FDA supports the use of 
IV acetaminophen for: “1) the management of mild to moderate pain; 2) the management 
of moderate to severe pain with adjunctive opioid analgesics; and 3) the reduction of 
fever in adults and children (age ≥ 2 years)” (Pasero & Stannard, 2012, p. 108). 
Because IV acetaminophen avoids the first-pass metabolism, the drug spares the 
liver from 50% of exposure compared to the oral or rectal form of acetaminophen (Lewis, 
2012).  The elimination of the first-pass metabolism and the rapid onset of IV 
acetaminophen is quicker and more predictable than other available routes (Pasero & 
Stannard, 2012).   
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Cost of Acetaminophen 
Despite the reported benefits and the elimination of the hepatic first pass 
metabolism, the cost of the product decreases its availability (McKee, 2014).  When the 
price of IV acetaminophen increased 140%, from approximately $14.00 per 1 gm vial to 
$35.00 per 1 gm vial (Dungy & Prince, 2015) many hospitals responded to the substantial 
rise in costs by decreasing their use of the product, thereby decreasing the availability of 
the drug. 
Acetaminophen Mechanism 
IV acetaminophen is an analgesic and an antipyretic with a site of action that is 
speculated to occur at the central nervous system (Lachiewicz, 2013).  Its analgesic 
properties are theorized to act by inhibiting prostaglandins, which then act peripherally 
by blocking pain impulses, specifically a cannabinoid receptor agonist mechanism, a 
serotonergic (5-HT) mechanism, cyclooxygenase-3 isoenzyme inhibition, and TRPV- 
agonist (Lachiewicz, 2013).  The antipyretic effect also is caused also by prostaglandin 
inhibition within the hypothalamus and the subsequent blocking of the cannabinoid 
agonist mechanism (Pasero & Stannard, 2012).   
Route Comparisons Supporting IV Administration 
In comparisons of by mouth (PO), per rectum (PR), and IV forms of 
acetaminophen, the IV form has significantly higher peak concentrations in cerebrospinal 
fluid (CSF) because high plasma concentrations are readily able to cross the blood brain 
barrier (Lachiewicz, 2013).  This is important, since acetaminophen is believed to work 
centrally.  Passive diffusion of acetaminophen into the central nervous system via the 
blood brain barrier is dependent on Cmax (maximum plasma concentration of drug) since 
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active transport does not occur (Singla et al., 2012).  Also, there is less variability in the 
plasma concentrations in cases where IV acetaminophen is delivered instead of the PO or 
PR form (Singla et al., 2012).   
The advantages of the IV form of acetaminophen over the PO route lie primarily 
in its concentration and its onset time.  For acetaminophen to be an effective analgesic, 
serum therapeutic level should be 16 mcg/mL in adults (Golembieewski & Mueller, 
2011).  It takes 45 minutes for the onset of action to occur for 1,000 mg of PO 
acetaminophen and most patients are unable to reach median plasma concentrations of 
12mcg/mL (Golembieewski & Mueller, 2011).  The PR form of acetaminophen is 
unpredictable, and the maximum plasma concentration (Tmax) time can take up to three 
to four hours (Lachiewicz, 2013).  In contrast, IV acetaminophen can reach Tmax of 19 
mcg/mL within 15-30 minutes (Lachiewicz, 2013).   
Acetaminophen is generally safe for adults when taken in doses no greater than 
4g/day, and in doses of 2-3 g/day for chronic use (Groudine & Fossum 2011).  
Acetaminophen toxicity can occur in doses greater than the recommended amount. Also, 
acetaminophen is an ingredient in cold and sinus medicines and other over-the-counter 
medications.  This can be a safety concern when these medications are used in 
combination with prescribed medications.  However, these concerns can be addressed 
and alleviated in the hospital setting with diligent pharmacy, physician, and nursing 
supervision.   
Acetaminophen should be used with caution or avoided in patients with acute 
liver disease or hypersensitivity to acetaminophen, as hepatotoxicity is a major safety 
concern (Golembieewski & Mueller, 2011).  Underlying causes of hepatotoxicity can 
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include alcohol abuse, liver steatosis, depletion of glutathione stores, and chronic 
malnutrition.  Acetaminophen is metabolized by the liver through 3 enzymatic pathways: 
glucuronidation, sulfation, and oxidation (Lachiewicz, 2013).  The renal system is 
responsible for excreting 3-5 percent of metabolized acetaminophen; therefore, this is a 
medicine that should be avoided in patients with severe hypovolemia or severe renal 
impairment.   
Hepatotoxicity from the absorption of PO acetaminophen can result in high 
concentrations in the portohepatic circulation resulting from the first pass effect 
(Lachiewicz, 2013).  IV acetaminophen avoids the hepatic first pass effect but is able to 
accomplish higher plasma concentrations.  However, there is no supporting evidence to 
show that giving IV acetaminophen will result in less hepatotoxicity than occurs with the 
PO or PR forms. 
Intravenous Acetaminophen Administration 
While the mechanism of action is unclear, there are many benefits from IV 
acetaminophen.  Unlike opioids, IV acetaminophen neither increases the incidence of 
nausea and vomiting or respiratory depression.  The drug does not cause platelet 
dysfunction that can contribute to gastritis or interfere with renal function, like many 
nonsteroidal anti-inflammatory inhibitors (NSAIDs) are known to do (Pasero & Stannard, 
2012).   
After the administration of IV acetaminophen, the onset time for action occurs 
between 5 to 10 minutes, and peaks after 1 hour for analgesia purposes (Nagelhout & 
Plaus, 2014).  The medication lasts between four to six hours after its infusion.  Also, IV 
acetaminophen has been shown to have higher peak plasma and cerebrospinal fluid (CSF) 
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maximum concentrations than oral or rectal suppository forms (Singla et al., 2012).  
These concentrations also peak earlier compared to the oral (PO) and suppository form 
(PR) of acetaminophen.  It should also be noted that IV acetaminophen’s Cmax is nearly 
twice that of the PO form of acetaminophen and almost four times greater than that of the 
PR form of acetaminophen (Singla et al., 2012).  This means that the IV form of 
acetaminophen results in a faster onset, making it more advantageous compared to the 
other routes of administration. 
Summary 
CS are increasing every year and pain management in this population is 
concerning.  If surgical pain for the CS patient is not treated effectively, serious 
complications such as depression and chronic pain can occur.  Traditionally opioids have 
been used to treat postoperative pain but are known to have serious, negative side effects.  
It is recommended by the American Society of Anesthesiologists Task Force on Acute 
Pain Management to use a multimodal approach to treat pain.   
Multimodal therapy is designed to use nonopiod analgesics to treat pain and opioids are 
given as supplemental breakthrough agents.  IV acetaminophen is proven to be a safe and 
effective drug when used properly and is a favorable choice for multimodal therapy.  
Although the cost of IV acetaminophen has increased, it is more beneficial when 
compared to other forms of acetaminophen. 
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CHAPTER II – REVIEW OF LITERATURE 
A systematic search for current articles was conducted using Cochrane, Pub Med, 
Nursing Ovid, Medline, CINHAL, Joanna Briggs Institute, and Google Scholar, Agency 
for Healthcare Research and Quality, and National Guidelines Clearinghouse.  Search 
terms were:  ofirmev and postoperative pain management, intravenous (IV) Tylenol and 
postoperative pain control, paracetamol and cesarean section, guidelines for 
postoperative pain control for CS patients, and IV acetaminophen and c-sections and 
reduction of pain.  This search returned 525 publications.  
Included articles were five years current, written in English, manufacture-
produced publications, and related to a multimodal analgesic regimen. Articles were 
excluded if:  they were written in a language other than English, ongoing studies, partial 
studies, used animals as test subjects, demonstrated conflicts of interest, or irrelevant to 
CS patients receiving IV acetaminophen as a multimodal analgesic regimen.  Since there 
was limited data for IV acetaminophen used as a multimodal approach to pain 
management for CS patients, this project synthesizes the published literature about:  (a) 
IV acetaminophen for pain management, (b) different surgeries that implement IV 
acetaminophen for multimodal pain reduction, and (c) benefits with IV acetaminophen 
for CS.  Thirteen peer-reviewed articles were relevant to IV acetaminophen used in a 
multimodal approach to pain management. Three of those articles are relevant to CS 
patients.   
Intravenous Acetaminophen for Pain Management 
In a qualitative report, Groudine and Fossum (2011) examined the results of eight 
different studies with multiple surgical procedures.  Studies included manufacture 
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produced publications, randomized, double-blind, placebo-controlled, multicenter, 
multiple-dose studies, and a meta-analysis of randomized, prospective trials.   These 
results showed the safety and efficacy of IV acetaminophen for various procedures, 
including pediatric and pregnant patients.  These authors observed that the 
implementation of IV acetaminophen had a positive impact on patient care when used in 
a multimodal therapy to treat acute surgical pain.  Additionally, the study results revealed 
a reduction in pain when IV acetaminophen was used in major surgical procedures.  
Groudine and Fossum (2011) concluded that IV acetaminophen is relatively safe, but 
should be used with strict clinical supervision because it is contained in many over-the-
counter medications and oral narcotics.  If medications are not monitored closely, there is 
an increased risk of exceeding the recommended daily allowance of acetaminophen.  The 
authors also acknowledged that hepatic damage is related to overdose of acetaminophen 
and contraindicated in patients with hepatic impairments (Groudine & Fossum, 2011).  
Even so, IV acetaminophen could be a reasonable component of NOPAs because it is not 
associated with increased bleeding after surgery and does not affect kidney function 
(Groudine & Fossum, 2011). 
Pasero and Stannard (2012) performed a qualitative, case-illustrated review study 
showing the benefits of IV acetaminophen.  The information revealed the results from 
various case studies, including laparoscopic surgeries, major abdominal procedures, 
major orthopedic surgeries, dental procedures, and pediatric procedures.  This case 
review evaluated the safety and effectiveness of IV acetaminophen and concluded that 
the medication is beneficial for the use as an adjunct, along with other opioids, for 
multimodal pain control (Pasero & Stannard, 2012).   
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It was revealed for major abdominal surgeries, 40 patients were randomized to 
receive either 1000 mg of IV acetaminophen every six hours and IV meperidine for 
breakthrough pain or placebo, which was IV saline every six hours and IV meperidine as 
needed within a 24-hour time period.  The treatment group needed less postoperative 
meperidine (p < 0.05) and their visual analog scale (VAS) scores were lower (p < 0.01) 
when compared to the control group (Pasero & Stannard). 
IV acetaminophen has been shown to retain its safety features, even though it 
reaches a higher maximum concentration (70%) and faster onset than with PO and PR 
administrations.  These findings help secure IV acetaminophen’s standing as an attractive 
component for multimodal pain relief, based on its ability to reduce the need for narcotics 
after surgery, thus reducing the risk of adverse opioid–related events (Pasero & Stannard, 
2012).  Adding IV acetaminophen could potentially have a dramatic impact on patient 
recovery rates, as it could facilitate mobilization and rehabilitation, which could mean 
reductions in health care costs and improvements in reported patient satisfaction (Pasero 
& Stannard, 2012).  
Macario and Royal (2011) performed a meta-analysis to assess the analgesic 
benefits of IV acetaminophen for postoperative pain management for adults.  
Randomized, controlled trials (RCTs) comparing IV acetaminophen vs. an alternative 
analgesic or a placebo were retrieved from Medline and Cochrane library for the meta-
analysis.  From the RCTs, 22 studies were compared: IV acetaminophen vs. an 
alternative analgesic, such as parecoxib, IV metamizol, and PO ibuprophen, (n = 8 
studies) and IV acetaminophen vs. a placebo (n = 14) (Macario & Royal, 2011).  The 
results showed similar outcomes between IV acetaminophen and an alternative analgesic. 
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However, when the IV acetaminophen was compared to the placebo, 12 of the 14 
studies found that IV acetaminophen patients experienced less pain (Macario & Royal, 
2011).  Even more impressive, 10 of the 14 placebo studies showed that when patients 
received IV acetaminophen, they not only needed fewer opioids overall and percentages 
of opioids for rescue pain, but also waited longer time intervals before needing opioids 
for pain relief (Macario & Royal, 2011).   
De Oliveira, Castro-Alves, and McCarthy (2015) conducted a meta-analysis that 
implemented the random-effect model.  The purpose of the study was to determine the 
effects of pain outcomes when a single dose of systemic acetaminophen is delivered 
before surgery in both adults and children.  In this analysis, 11 RCTs were used to 
evaluate 740 patients, 375 having received a single dose of IV acetaminophen and the 
remaining 365, controls, receiving a placebo.  The Jadad Scale was used to grade the 
RCTs and the median, and the interquartile range was four.  From the 11 RCTs, nine 
studies evaluated the effect of systemic acetaminophen and noted its ability to help 
reduce postoperative opioid consumption when compared to the control (De Oliveira et 
al., 2015).  There was a reduction of opioids needed by patients when given IV 
acetaminophen compared to placebo, weighted mean difference (WMD) of -9.7; 95% CI 
(-13.0 to -6.4).  Also, the study showed IV acetaminophen was useful in a reduction of 
early pain at rest (≤ 4 h, -1; (95% CI (-2.0 to -0.2)) and pain at movement immediately 
postoperatively (24 h, -1.9; (95%CI (-2.8 to -1.0)) when compared to the control.  From 
this information, the researchers concluded that a single dose of IV acetaminophen is a 
valuable medication to help diminish postoperative pain (De Oliveira et al., 2015). 
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Konstantatos, Smith, and Angliss (2012) investigated whether the addition of IV 
acetaminophen administration helped reduce discharge times in ambulatory surgery 
centers.  For this study, 145 patients were divided as follows: pre and postoperative 
placebo (n = 50), operative IV acetaminophen and postoperative PO acetaminophen (n = 
49), and pre and postoperative PO acetaminophen (n = 48).  The authors determined that 
time ready for discharge from the postoperative care unit did not vary among the three 
groups (Konstantatos et al., 2012). 
The researchers noted several limitations that may have impacted this study’s 
conclusions.  The dominant population of this study was young males having minor 
orthopedic and plastic surgery at only one ambulatory surgery center (Konstantatos et al., 
2012).  Healthy young males with an ASA I or II are less likely to develop respiratory 
depression or other side effects of opioids that are seen in older patients, patients with co-
morbidities, and obese patients (Konstantatos et al., 2012).  Another weakness of the 
study could have been related to surgeons infiltrating local anesthetics at the site of 
incision and anesthesia personnel using fentanyl or other opioids.  The aim of the study 
was to avoid altering the typical flow and treatment options used at the surgery center 
(Konstantatos et al., 2012). 
Surgeries Implementing Intravenous Acetaminophen for Multimodal Pain Reduction 
Gynecological Procedures 
Wininger et al. (2010) conducted a double-blind, placebo-controlled, parallel-
group study in 17 different facilities throughout the United States.  A total of 244 
abdominal laparoscopic surgery patients were placed into four groups randomly: (a) IV 
acetaminophen 1 gm in 100 mL every 6 hours, (b) IV acetaminophen 650 mg in 65 mL 
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every 4 hours, (c) 100 mL of IV placebo every 6 hours, and (d) 100 mL IV placebo every 
4 hours.  All medications were given over a 15-minute period for 24 hours after surgery.  
The results showed that both IV acetaminophen groups outperformed the two placebo 
groups in terms of pain relief, reducing the weighted sum of pain intensity over a 24-hour 
period (1000 mg, p < 0.0007; 650 mg, p < 0.019) (Wininger et al., 2010). 
Another study revealed that IV acetaminophen was given preoperatively and the 
medication’s analgesic effects were assessed in 76 women who elected to have 
abdominal hysterectomies (Moon, Lee, Lee, & Moon, 2011).  This study was a 
randomized, double-blinded and placebo-controlled, and was designed to learn whether 
IV acetaminophen administered prior to surgery would decrease pain scores, lessen the 
need for opioids, and reduce side effects. These patients were divided into two groups:  
Group A, IV acetaminophen 2 gm, 30 minutes before surgery with general anesthesia and 
Group C, IV placebo 30 minutes prior to surgery with general anesthesia.  The results 
showed less need for opioids in Group A compared to group C (p = 0.013) (Moon, Lee, 
Lee, & Moon, 2011).  It was noted that postoperative nausea and vomiting was also lower 
in Group A (p = 0.05) when compared to group C.  Even though the patients in Group A 
needed fewer opioids and experienced less SE after surgery, they did not report a 
reduction in pain intensity (Moon et al., 2011).  
Spinal Procedures 
An IV acetaminophen group used significantly less opioids (p = 0.015) compared 
to the control group in a retrospective analysis conducted by Smith and Hoefling in 2014.  
The analysis reviewed 68 EMRs, including 34 patients who were selected to be in the 
control group and 34 spinal surgery patients who underwent spinal fusions with anterior 
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or posterior approaches and received IV acetaminophen either preoperatively or 
postoperatively (Smith & Hoefling, 2014).  Members of the control group were close in 
age and gender to members of the medication group; they had the same surgery 
performed by the same surgeon, and received only opioids for pain control (Smith & 
Hoefling, 2014).  Results indicated that here was a decreased need for opioids (11.3 mg 
morphine equivalent [ME]) in the group that received IV acetaminophen compared to the 
control group (20.6 ME).  Both groups were similar when it came to VAS scoring, and 
needing post-surgery anti-emetics and laxatives (Smith & Hoefling, 2014). 
Orthopedic Procedures 
Total hip arthroplasties (THA) represent one of the most common 
musculoskeletal surgeries and one of the most arduous to handle in terms of pain 
management, due to comorbidities and to the advanced age of patients undergoing the 
procedure (Singla et al., 2014).  Two double-blind, parallel-group, multicenter, 
randomized, placebo-controlled clinical trials were conducted on 130 participants with 
similar demographics to determine efficacy and safety of a single-dose IV acetaminophen 
for patients who underwent THAs.  IV acetaminophen when compared to placebo, shows 
a higher mean pain intensity difference (PID) with significant (p < 0.5) differences in 
treatment arms.   
Study one results indicated that pain relief scores were superior with IV 
acetaminophen beginning at T0.25, and study two results put it superior beginning at 
T0.5.  Both studies continued to show favorable relief scores until T4.  Rescue opioid 
consumption was reduced for up to six hours in study one and almost four hours in study 
two with IV acetaminophen.  Essentially, both studies show that IV acetaminophen is an 
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effective multimodal analgesic, which has a rapid onset, decreases rescue medication, 
decreases opioid consumption by 50 percent, and reduces moderate-to-severe pain after 
THAs compared to placebo. 
Benefits of Intravenous Acetaminophen for Cesarean Section 
Kamath and Lasrado (2014) compared the efficacy of 2 gm butorphanol (an 
opioid) versus1 gm intravenous acetaminophen for elective cesarean sections and routine 
gynecological procedures in a randomized parallel-group controlled trial.  The 51 patients 
in Group A were given 1 gm of IV acetaminophen every eight hours.  The 50 women in 
Group B received butorphanol 2 gm every 12 hours (Kamath & Lasrado, 2014).  Pain 
was measured by VAS scales at rest and while the patient inhaled deeply.  These scores 
were measured after 30 minutes, 2 hours, 4 hours, 6 hours, 8 hours, and increased to 12 
hours, and 24 hours.  Tramadol 100 mg IV was the rescue medication given if the pain 
intensity was greater than five (Kamath & Lasardo, 2014). 
Kamath and Lasrado’s (2014) results indicated that the Group B had better pain 
ratings at 2 hours than Group A (3.613 vs. 4.20).  The pain ratings in both groups 
continued to decrease overtime and overall, the authors concluded that Group A was an 
effective and safe analgesic and it provided better pain-control at 6 hours, 8 hours, and 24 
hours than Group B (p = 0.02).  The remaining time intervals show no statistically 
significant difference between the two groups (Kamath & Lasardo, 2014).  The study 
results illustrated less rescue medication was needed in Group A (68%) than Group B 
(92%) which concluded that there was a statistically significant difference (p = 0.003) 
favoring IV acetaminophen to butorphanol (Kamath & Lasrado 2014). 
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The authors advised that IV acetaminophen is not a good choice for monotherapy 
for pain control, but noted that when used in combination with other opioids, it reduced 
the side effects commonly seen with opioids (Kamath & Lasrado, 2014).  Side-effects 
reported included: sedation was not seen in Group A and Group B reported 47%; nausea 
for Group A was 4 % compared to 14% for Group B; and Group A revealed it had less 
sleep disturbances (8%) compared to Group B (25%) (Kamath & Lasrado, 2014). 
A randomized, double-blind, double-dummy, parallel group placebo-controlled 
clinical trial, 111 women had elective CS with spinal anesthesia, followed by a patient-
controlled epidural (Paech, McDonnell, Sinha, Baber, & Nathan, 2014).  Group C, the 
control group consisted of 23 women, who received a placebo, and Group PC had 30 
women and they received 40 mg of IV parecoxib along with PO celecoxib 400 mg every 
12 hours along with placebos.  Group PA had 32 subjects and they received 2 gm IV 
paracetamol (IV acetaminophen) along with 1 gm PO paracetamol at 6, 12, and 18 hours 
along with placebos (Paech et al., 2014).  Group PCPA had 26 women to receive 40 mg 
IV parecoxib and 2gm IV paracetamol, followed by 1 gm PO paracetamol at 6,12, and 18 
hours in combination with 400 mg PO celecoxib. 
The results of this study concluded that all three groups continued to need pain 
control from the pethidine epidural (Paech et al., 2014).  The dynamic pain scores, as 
measured by the verbal numerical rating score, were not different in the groups, but the 
need for PO tramadol was least needed in the PCPA group (incidence 23% versus 48%, 
70% and 58% in groups C, PC, and PA respectively, p = 0.004).  The incidence of nausea 
and sedation was stable in all groups, with very little degree in differences (range 9% to 
19%) (Paech et al., 2014).  Concomitant pruritus and its severity were much greater in all 
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groups when compared to the control group (69%, 69% and 62 % versus 30%, p = 
0.016).  These results concluded that delivering COX-2 inhibitors and paracetamol, alone 
or in combination, does not reduce patients’ decision to self-administer pethidine epidural 
analgesia (Paech et al., 2014). 
Darvish and colleagues (2013) illustrated that the combination of IV 
acetaminophen and diclofenac has a better efficacy for controlling postoperative pain and 
reduced the need for additional opioid consumption.  The authors selected 120 women 
candidates.  These candidates were randomly placed into two groups.  Group A 
participants received a diclofenac suppository at the end of CS with an additional 1 gm 
infusion of IV acetaminophen.  The second group, Group B, received 20 mg bolus of 
meperidine while transitioning to the recovery room (Darvish et al., 2013). 
Postoperative pain was noted in the recovery room 23.3% and 38.3% in Group A 
and Group B, respectively (p=0.009). Six hours after the procedure, postoperative pain 
was assessed and noted to be 16.7% and 38.7% in Groups A and B, respectively 
(p=0.010).  Twelve hours after the procedure, pain was present and assessed to be 15% 
and 38.3% for Groups A and B, respectively (p=0.002) (Darvish et al., 2013). Meperidine 
was used as a supplement for pain control for both Groups A and B 6 hours after the CS 
and the pain present was noted 6.7% and 26.7%, (p=0.013). 
Meperidine was used as a supplemental medication for breakthrough pain 12 
hours after surgery and pain present was none and 16.7%, for patients in Groups A and B, 
respectively (p=0.004) (Darvish et al., 2013).  The authors noted that the adverse effects 
from the medications used in both groups were the same (p > 0.05).  From the 
information gathered, it appeared that the multimodal combination of diclofenac and IV 
 20 
acetaminophen was a better postoperative pain control method when compared to 
meperidine alone (Darvish et al., 2013). 
Review of Literature Summary 
Opioids are known to have many undesirable side effects.  However, IV 
acetaminophen has proven to be a safe and efficient means of reducing opioid 
consumption.  To date, no clear or established guidelines are in place for reducing post-
operative pain for CS patients (Darvish et al., 2013).   Since IV acetaminophen’s 
introduction to the United States, however, many studies have shown its importance as a 
multimodal agent for reducing the need for opioids in various surgical procedures.  This 
information is limited within the CS delivery population.  Through the implementation of 
IV acetaminophen, a safer and more reliable approach to pain control can be 
implemented for CS patients.  Since many opioids do contain acetaminophen, it is 
important to monitor the amount of acetaminophen consumed by the patient.  Proper 
clinical supervision can prevent exceeding the maximum daily dose of acetaminophen. 
Theoretical Framework 
Implementing evidence-based practice guidelines, the anesthesia provider or 
nurse anesthetist (CRNA) will ensure the best available health care techniques resulting 
in favorable patient outcomes.  Due to the complexity of healthcare, models or theories 
can offer a framework to achieve a maximum level of wellness for patients (Riehl & Roy, 
1980). Theories influence the way anesthesia providers base and formulate methods to 
implement the best care and speed of recovery for their patients.  The application of the 
appropriate theory may encourage better techniques of nurse anesthesia practice for 
promoting relief of pain for the CS patient.  
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Neuman systems model was introduced in the 1970s for nursing education and 
practice.  This theory has undergone many refinements, but remains a holistic approach 
to guiding nursing practice.  The Neuman model is an open system model that deals with 
stress and reactions in relation to a client or group (Neuman & Fawcett, 2002).  The 
theory posits that clients or groups are in a constant state of fluctuation, either moving 
towards wellness or illness (Neuman & Fawcett, 2002).  The goal is for a patient to 
achieve harmony and stability when faced with internal or external stressors (Neuman & 
Fawcett, 2002).   
Each individual is considered unique and possess characteristics that are 
considered normal within a basic structure (Neuman & Fawcett, 2002).  Neuman’s model 
shows the interrelationship of five variables that can affect the patients’ well-being: (a) 
physiological, (b) psychological, (c) sociocultural, (d) developmental, and (e) spiritual 
(Butts & Rich, 2015).  These variables aid in adapting to stressors, whether stressors are 
good or bad.  According to Neuman and Fawcett (2002), these variables are part of the 
client’s basic structure, as well as the normal and flexible lines of defense (LOD) and the 
lines of resistance that aid in maintaining balance for the patient’s core (Neuman & 
Fawcett, 2002). 
Neuman’s Systems Model Diagram Explained 
Neuman explains her theory by using a diagram.  The illustration shows a circular 
module and it is known as the basic unit or the patient’s core.  It is surrounded by lines of 
resistance and a normal and flexible LOD.  The LOD are in place to ensure the stability 
of a patient when threatened by known or unknown stressors (Neuman & Fawcett, 2002).   
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The flexible LOD is the outermost boundary surrounding the core and acts as a 
buffer to protect the patient’s stable state (Neuman & Fawcett, 2002).  This line is 
dynamic and can adapt to an emergent situation or other medical conditions, such as 
dehydration or depression.  If the flexible LOD is penetrated, the patient will exhibit 
symptoms related to the stressor (Neuman & Fawcett, 2002).    
The normal LOD is protected by the flexible LOD (Neuman & Fawcett, 2002). 
The normal LOD is known to be dynamic, expanding or contracting over time.  The 
normal LOD and the five client variables represent the patient’s standard state of health 
(Neuman & Fawcett, 2002).  However, deviation from this standard determines the extent 
of damage received by the stressor.  Stability of the patient’s core can increase, diminish, 
or stay the same based on the normal LOD ability to deal with internal or external 
stressors (Neuman & Fawcett, 2002).    
The innermost boundary protecting the patient’s core is the line of resistance 
(Neuman & Fawcett, 2002).  If the normal LOD are ineffective to an environmental 
stressor, the lines of resistance aid in protecting the core’s integrity (Neuman & Fawcett, 
2002).  Effective lines of resistance assist in reversing damage from stressors and 
reestablishing order of the system.  However, if the lines of resistance prove ineffective, 
permanent damage or death may result (Neuman & Fawcett, 2002). 
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Figure 1. Adaptive Framework of Neuman’s Model for CS Patients 
Prevention Measures 
Neuman’s model is composed of primary, secondary, and tertiary preventions 
used to deal with environmental stressors (Neuman & Fawcett, 2014).  All three 
prevention modalities act as interventions depending on the patient’s condition.  Based on 
the patient’s stressors and conditions, these interventions can occur either alone or 
simultaneously (Zaccagnini & White, 2014).  
Primary prevention is known as an intervention and wellness retention (Neuman 
& Fawcett, 2002).  Primary intervention is used when there is a known threat to the 
patient’s basic structure but has not occurred.  This primary prevention helps enable or 
strengthens a system’s ability to cope with stressors, possibly even before the stressor can 
affect the system (Butts & Rich 2015).  
If the primary prevention is ineffective, the secondary prevention is needed to 
protect the patient’s core by strengthening the internal lines of resistance (Neuman & 
Patient's
Core
Primary Prevention: 
Scheduled doctor's visits, 
prenatal care, proper diet 
and exercise, adequate rest
Secondary 
Prevention:  
Multiimodal therapy 
with IV 
acetaminophen prior 
to CS 
Tertiary Prevention:  
Scheduled dosing of IV 
acetaminophen to help 
reduce opioid 
consumption, improved 
comfort, and return to 
wellness
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Fawcett, 2002).  This can be achieved by treating symptoms to provide optimal wellness 
and stability.  If the secondary prevention is ineffective, the patient’s core is irreparably 
damaged.  But, if the secondary prevention is adequate, reestablishment is made and the 
system can return to its previous level of function or stabilize to a lower or even higher 
level of functioning (Neuman & Fawcett, 2002). 
The tertiary prevention is utilized when the secondary prevention is proven to be 
effective.  Once the patient begins to return to their normal state of wellness, the tertiary 
prevention promotes wellness maintenance (Neuman & Fawcett, 2002).  With the success 
of tertiary intervention, the patient’s wellness and conservation of energy leads back to 
primary prevention (Neuman & Fawcett, 2002). 
The doctoral project showed how the anesthesia provider can integrate the 
Neuman model in their practice when treating CS patients.  The patient maintains her 
health throughout her pregnancy with primary prevention.  Primary prevention can be 
accomplished by regular doctor’s visits, prenatal vitamins, proper diet and exercise, and 
adequate rest.  If the obstetric physician determines that a CS will be the best method for 
delivery, it is the anesthesia provider’s goal to ensure a safe and effective means of pain 
control, since surgery will be a stressor.  The anesthesia provider can provide the 
secondary prevention by infusing IV acetaminophen preoperatively and providing an 
effective subarachnoid block containing intrathecal morphine.  This intervention can 
reduce the amounts of opioids postoperatively which leads to the tertiary prevention.  The 
tertiary intervention occurs when the patient is returning to her normal, stable state.   
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Essentials of Doctoral Education for Advanced Nursing Practice 
The American Association of Colleges of Nursing (AACN) notes the practice-
focused doctoral programs must require “a scholarly approach to the discipline, and a 
commitment to the advancement of the practice” (AACN, 2006, p. 3).  The AACN urges 
nurses who are expanding their knowledge for advanced care become experts for 
scientific investigation and develop strong leadership skills.  Ensuring the advanced nurse 
is competent for specialized practice, the AACN require these essentials to be 
incorporated in the education of the DNP degree. 
Essential I 
Essential I described the scientific underpinnings for practice and it is the 
foundation of nursing practices (Chism, 2013).  This essential integrates nursing theories 
to guide practice which ensures optimal wellness of patients.  Neuman’s model is the 
framework for this doctoral project.  This project’s aim was to show that the use of IV 
acetaminophen used in a multimodal approach to pain therapy can help reduce the need 
of opioids in CS patients. 
Essential II 
DNP essential II explored the advancement of quality and safe healthcare delivery 
methods through scientific findings in nursing (Chism, 2013).  The rates of cesarean 
delivery in the United States continue to rise. This project’s purpose was to show the 
addition of IV acetaminophen used in a multimodal approach for pain therapy may 
reduce postoperative pain and decrease the need for opioids for the CS patient. 
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Essential III 
This essential focused on the integration of new research findings into nursing 
practice (Chism, 2013).  In order to accomplish change, there is a need for quality 
improvement.  By researching the literature and by a thorough collection of data, 
improvements to clinical outcomes can be implemented (Moran, Burson, & Conrad, 
2014).  Currently, no guidelines exist for pain control for the CS patient.  This project’s 
aim was to show that a multimodal approach to pain could be a safer and more effective 
means of reducing pain in the CS patient.  Adding IV acetaminophen preoperatively and 
scheduled doses postoperatively should reduce the amounts of opioids needed 
postoperatively. 
Essential IV 
Chism (2013) illustrated that DNP graduates can improve patient care through 
information technology with this essential.  Information for this project was compiled by 
using electronic databases.  Peer-reviewed journals were located and suggested that 
improper pain management techniques for CS patients can lead to chronic pain and 
depression. This information indicated that a solution is necessary to improve pain 
management in this particular population.  The utilization of electronic medical records 
was necessary to discover information for data analysis for this project. 
Essential V 
This essential accentuated the need for the DNP graduate to become involved 
with healthcare policy and advocacy (Chism, 2013).  Once the advanced practice nurse 
becomes fluent with policies, this enables and prepares leadership positions for the DNP 
graduate.  The results of this doctoral project may influence a change in practice by 
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promoting the need of a guideline to reduce pain for the CS patient.  This guideline 
would incorporate the use of NOPAs, specifically IV acetaminophen to reduce the need 
of opioids. 
Essential VI 
This essential described the importance of collaboration between healthcare 
professionals (Chism, 2013).  Professional collaboration can provide safe, effective, and 
timely patient care.  This project showed the safety and efficacy of IV acetaminophen 
used in parturients who will deliver via cesarean section.  The results of this project can 
help inform health care professionals of the benefits of a multimodal drug regimen to 
reduce opioid consumption.  
Essential VII 
Chism (2013) informed that essential seven illustrates that the advanced nurse is 
important for clinical prevention and improving the nation’s health.  Improper pain 
management in CS patients can lead to chronic pain, depression, and interfere with 
mother and infant bonding.  This doctoral project entailed statistical analysis of pain 
outcomes by comparing those who received IV acetaminophen and those who did not.  
Statistical evaluation can show that the addition of IV acetaminophen can possibly 
improve pain scores and reduce the need of opioids in this patient population. 
Essential VIII 
The last essential ascertained that even though nursing is diverse, it is required for 
the DNP graduate to be an expert in at least one area of nursing practices (Chism, 2013).  
In order to complete this project, information was gathered and reviewed.  Furthermore, 
the literature recommendations were put into practice to evaluate the effectiveness of IV 
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acetaminophen used in a multimodal regimen for CS patients.  Inferred statistical analysis 
can be presented and reported for educational advancement. 
Summary of Neuman Systems Model and DNP Essentials 
Theories are tools that can be used to maximize the anesthesia provider’s methods 
to assist patients to return to their normal state of functioning.  The Neuman systems 
model is a wellness model that defined three interventions to enable a patient to return 
their prior functioning level.  If lines of resistance and lines of defense fail from the result 
of external or internal stressors, primary, secondary, or tertiary interventions work 
independently or in tandem to achieve maximum wellness for the patient.  The anesthesia 
provider can aid the cesarean section patient achieve maximum comfort postoperatively 
through a multimodal anesthesia technique.  This multimodal technique combines 
neuraxial anesthesia with the addition of IV acetaminophen prior to surgical incision.  IV 
acetaminophen can potentially help reduce the amounts of opioids needed postoperatively 
and encourage a faster and recovery of the patient. 
DNP essentials can help ensure best care practices of the nurse anesthetist by 
encouraging the advanced nurse to become an expert in a certain area.  The essentials 
encourage the advanced practice nurse to develop a complete course of action to care for 
the patient most sufficiently.  Through advancing technology, integrating new research in 
nursing practice, collaborating with other healthcare providers, and becoming involved 
with healthcare policy and advocacy, the advanced nurse is more effective and can help 
improve overall patient satisfaction. 
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CHAPTER III  - METHODOLOGY 
Design 
This project is a quantitative study that compared the relationship between 
mothers with CS who were given preoperative IV acetaminophen (Group A) and those 
mothers who did not (Group C) in order to determine the opioids used within 24 and 48-
hour time period, length of hospital stay, and the amount time of first request of pain 
medication.  The project incorporated the use of the independent t-test and Cohen’s d test 
to measure the means and effect size of both groups.  A cross sectional, retrospective 
chart review with quota sampling was used for the collection of data.  A power analysis 
with alpha of 0.05 and an effect size of 0.4 indicated that 200 subjects were needed for 
each group (https://www.ai-therapy.com/psychology-statistics/sample-size-calculator). 
Sample 
The sampling frame consisted of women who presented for elective CS at a 211-
bed hospital in southeast Mississippi between January 2014 through September 2016. 
Following IRB approval from USM and host facility charts were reviewed until 100 
cases meeting inclusion criteria for each group were identified.  Criteria selection 
consisted of cases regardless of parity, gravida, and presentation if they were: 
 English speaking women 
 American Society of Anesthesiologist Classification (ASA) I or II 
 Ages between 18-35  
 Gestation term of 37-42 weeks 
 Singleton and multiple births 
 Repeat CS 
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 Neuraxial block anesthesia 
 Pfannestiel surgical incision  
Exclusion criteria consisted of cases who had: 
 Emergent or urgent CS 
 Comorbidities that contributed to a higher ASA score 
 Chronic pain 
 Current infection 
 Greater than four hours of labor time 
 Liver and renal disease 
 Sensitivities or allergic reactions to acetaminophen 
 Patient-controlled analgesic pumps 
 ICU admission after delivery 
 General anesthesia or existing pain epidural 
 Transverse surgical incision 
Variables 
Independent variables for the project included: 
 ASA classification 
 Single or twin delivery 
 Race as identified by electronic health records (EHR) (Caucasian, African 
American, or Native American) 
 Age in years 
 Length of pregnancy in weeks 
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 Gravida defined as the number of pregnancies 
 Parity defined as number of viable births  
 Preoperative IV acetaminophen administration 
 Postoperative acetaminophen administration 
 Anesthesia start time 
 Analgesics given postoperatively within 24 and 48 hours of anesthesia start 
time measured in morphine milligram equivalents measured by standard 
conversion chart (See Appendix E) 
Dependent variables were: 
 Analgesics including opioids or nonsteroidal anti-inflammatory drugs 
measured in morphine milligram equivalents (MME) given within a 24 and 
48-hour time frame from anesthesia start time. 
 LOS time measured in hours, beginning with anesthesia start time until patient 
was discharged home. 
 Time of first request of pain medication was defined by the length of time 
between anesthesia start time and patient’s first request for pain medication 
regardless of patient location and disposition. 
Data Collection 
The independent and dependent variables were collected from the electronic 
medication administration record (eMAR) and the EHR and was placed in the Data 
Collection Form (Appendix D).  Data collected were entered into the Statistical Package 
for the Social Sciences (SPSS) (IBM SPSS Statistics for Windows, Version 19.0. 
Armonk, NY: IBM Corp) for data analysis. The de-identified data was stored on a 
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password-protected personal computer.  Data will be disposed by shredding or deleting 
from the hard drive six months after all graduation requirements and 
presentation/publication activities have been completed. 
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CHAPTER IV – ANALYSIS OF DATA 
The aim of this project was to explore the relationship between IV acetaminophen 
and postoperative pain in CS patients. To determine the clinical impact of preoperative 
IV acetaminophen on postoperative pain in CS patients t-test were conducted to 
determine if statistical significance differences in postoperative pain medications, LOS, 
and time of first request of pain medication existed between women who received IV 
acetaminophen (Group A) and those who did not (Group C). Data met assumptions for t-
test analysis. This chapter illustrates descriptive statistics and t-tests for four independent 
groups. 
Descriptive Statistics 
Descriptive statistics were used to describe cases in the sample including race, 
number of births, postoperative IV acetaminophen administration, gravida, parity, and 
pregnancy length.  All cases consisted of women who were classified as ASA II 
classification. The following table describes the sample. 
Table 1  
Descriptive Statistics 
Variable N Mean Standard 
Deviation 
Percentage 
(%) 
Caucasian 114 - - 57.00 
African American 85 - - 42.50 
American Indian 1 - - 0.50 
Single Births 194 - - 97.00 
Twin Births 6 - - 3.00 
Postoperative IV 
Acetaminophen  
90 - - 45.00 
Gravida 200 2.50 1.22 - 
Parity 200 1.23 0.87 - 
Length of Pregnancy 200 38.64 0.84 - 
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Bivariate Analysis 
The Pearson’s Chi-Square Test is an appropriate test for unpaired data, especially 
in large samples.  This test was utilized to determine whether there were significant 
differences with regard to ASA, race, and birth at baseline among those who received or 
those who did not receive IV acetaminophen preoperatively (Table 2).  The Pearson’s Chi 
Square Test illustrated that there was no significant statistical difference at baseline for 
race (p = 0.565).  Measures of association could not be computed for ASA and birth 
because there was no variability in the data.  No significant differences between the two 
groups were identified. 
Table 2  
Baseline Categorical Variables Using Pearson’s Chi-Square (n = 200) 
Categorical 
Variable 
Group A 
(n) 
(%) Group C 
(n) 
(%) p value 
ASA 100 100.00 100 100.00 NA 
Race 56 56.00 58 58.00 0.565 
Births (single 
v. twins) 
97 97.00 97 97.00 NA 
 
Table 3  
Baseline Continuous Variables Using An Independent t-test (n = 200) 
Continuous 
Variable 
Group A 
Mean 
(sd) Group C 
Mean 
(sd) p value 
Gravida 2.43 1.257 2.57 1.17 .417 
Parity 1.21 092 1.24 0.82 .808 
Weeks of 
Gestation 
38.63 0.91 38.66 0.78 .802 
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Assumptions for Independent t-test 
A series of two-tailed independent t-tests were used to determine if the 
administration of IV acetaminophen preoperatively decreased the total MME within 24 
and 48 hours, the total LOS, and the time of first request of pain medication.  Data met 
assumptions of normality and homogeneity of variance. See figures below. 
 
Figure 2. MME for 24 Hours Independent t-test  
Equal Variances Assumed 
There was no statistically significant difference in the scores for MME in the first 
24-hour for Group A (M = 47.01, SD = 25.95) and Group C (M = 45.06, SD = 25.93); t 
(198) = -0.55, p = 0.581.  Cohen’s d = 0.078.  These results indicate preoperative 
administration had no effect on postoperative use of analgesics at 24 hours.  Cohen’s d 
indicates there is a small effect size therefore, there is no statistical or practical 
differences between the two groups. 
 
Figure 3. MME for 48 Hours Independent t-test 
Equal Variances Assumed 
There was a statistical significant difference in the scores for MME in the 48-hour 
for Group C (M = 47.95, SD = 24.98) when compared to Group A (M = 58.69, SD = 
Group MME 
24 Hour 
MME
n Mean Std Dev SEM t df sig (2 
tailed)
Mean 
Diff
SE Diff 95% 
Lower 
Bound
95% 
Upper 
Bound
Cohen's 
d
C 100 45.06 25.93 2.59
A 100 47.01 23.95 2.40
Pooled 200 46.04 24.95 -0.55 198 0.581 -1.95 3.53 -8.92 5.01 0.078
Group MME 
48 Hour 
MME
n Mean Std Dev SEM t df sig (2 
tailed)
Mean 
Diff
SE Diff 95% 
Lower 
Bound
95% 
Upper 
Bound
Cohen's 
d
C 100 47.95 24.98 2.50
A 100 58.69 24.10 2.41
Pooled 200 53.32 24.54 -3.10 198 0.002 -10.74 3.47 -17.588 -3.9 0.438
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24.10); t (198) = -3.10, p = 0.002.  Cohen’s d = 0. 438.  These results indicate 
preoperative administration had no effect on postoperative use of analgesics at 48 hours 
and fewer analgesics were needed for Group C.  Cohen’s d indicates there is a small 
effect size therefore, there is no statistical or practical differences between the two 
groups. 
 
Figure 4. LOS Independent t-test 
Equal Variance Assumed 
There was a statistically significant difference in the scores for LOS for Group A 
(M = 50:24, SD = 5:12) compared to Group C (M = 52:19, SD = 6:31); t (198) = 2.31, p 
= 0.022.  Cohen’s d = 0.339.  These results indicate preoperative administration had an 
effect on LOS for CS women.  Cohen’s d indicates there is a small effect size therefore, 
there is no statistical or practical differences between the two groups. 
 
Figure 5. Time of First Request Independent t-test 
Equal Variance Assumed 
There was no statistically significant difference in the scores for time of first 
request of pain medication for Group A (M = 4:31, SD = 5:45) when compared to Group 
C (M = 5:22, SD = 5:35); t (198) = 1.04, p = 0.299.  Cohen’s d = 0.17.  These results 
Group LOS n Mean Std Dev SEM t df sig (2 
tailed)
Mean 
Diff
SE Diff 95% 
Lower 
Bound
95% 
Upper 
Bound
Cohen's 
d
C 100 52:19:00 6:31 0:39
A 100 50:24:00 5:12 0:31
Pooled 200 51:22:00 5:22 2.31 198.00 0.022 1:55 0:50 0:17 3:34 0.339
Group Time 
of First 
Request
n Mean Std Dev SEM t df sig (2 
tailed)
Mean 
Diff
SE Diff 95% 
Lower 
Bound
95% 
Upper 
Bound
Cohen's 
d
C 100 5:22:00 5:35 0:33
A 100 4:31:00 5:45 0:34
Pooled 200 1:00:00 0:40 1.04 198 0.299 1:55 0:48 -0.44 2:25 0.17
 37 
indicate preoperative administration had no effect on time of first request for pain 
medication.  Cohen’s d indicates there is a small effect size therefore, there is no 
statistical or practical differences between the two groups. 
Conclusion of Data Analysis 
An independent t-test was conducted to compare total MME with 24 and 48 
hours, LOS, and time of first request of pain medication for CS patients who received 
preoperative doses of IV acetaminophen compared with CS patients who did not receive 
IV acetaminophen preoperatively.  Data analysis revealed that LOS was statistically 
significant (p = 0.022) in Group A.  The need for MME within 24 hours and time of first 
request was not significantly different between the two groups.  Group C had a 
statistically significant decrease in MME within 48 hours (p = 0.002). 
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CHAPTER V – Conclusion 
Discussion of Results and Limitations 
The purpose of the retrospective chart review was to determine if the preoperative 
administration of IV acetaminophen reduced the amounts of MME needed post cesarean 
delivery within 24 and 48 hours, time for first intervention of analgesics, and length of 
stay for patients who received preoperative IV acetaminophen compared to those who did 
not.  No statistical significant difference was observed between the two groups for MME 
within 24 hours of CS delivery and the amount of time for first request of pain 
medication.  There was statistically significant difference that less MME were needed 48 
hours after CS for group C when compared to group A.  A statistical significant 
difference was reflected for those in Group A when comparing LOS.  Data was collected 
and noted the presence and absence of adverse reactions.  Fewer incidences of adverse 
reactions were documented for Group A when compared to Group C.  No statistical 
analysis was conducted. 
Neuman’s Logic Model was used as the framework for this doctoral project.  
Group A revealed a shorter LOS at the hospital.  The reduction of hospital stays aids with 
tertiary prevention.  Tertiary prevention is a means to revert back to a normal state of 
wellness.  This provides an opportunity for optimal wellness and stability. 
Limitations and Barriers 
Many limitations may have affected the results of the analysis.  Distinct responses 
to pain vary in each individual and can contribute to the inconsistent amounts of pain 
medication required by each patient after cesarean delivery.  Lack of consistency was 
observed in the administration times of IV acetaminophen prior to CS.  In addition, only 
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45 percent of patients continued to receive postoperative administrations of IV 
acetaminophen after surgery.  Scheduled NSAIDs were administered postoperatively to 
various patients while others did not receive this medication unless it was requested.  A 
0.4 effect size is a limitation because it is too small to find practical and statistical 
significance.  Sample size may not have allowed the test to be as robust for statistical 
findings. The use of four different t-tests could have increased error terms and impacted 
the analysis.  In addition, there could be an inherent difference between the literature’s 
population and the population used for this project. 
Time restrictions were a consistent barrier during data collection.  In order to 
begin chart review, credentialing had to be obtained from the host facility.  In addition, 
one person at the medical facility had authorization to upload charts into a query for 
review.  These charts could only be reviewed Monday through Friday during the hours of 
0800 to 1700.  
Recommendations 
It was noted that multiple types of opioids were used for breakthrough pain during 
and after surgery.  The literature revealed in other studies that only one type of 
medication was used for breakthrough pain.  Differences in mechanism of action and 
pharmacokinetics in various opioids and analgesics could cause variability and an 
increased amount of MME.  Scheduled dosing could have contributed to a higher amount 
of MME between groups.  A more consistent means of providing rescue medication and 
consistent IV acetaminophen administration times could have resulted in more favorable 
results and could be recommended for future studies. 
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Implications for Future Practice 
Future adverse drug reactions and expected sequelae of opioid administration can 
be reviewed.  It was observed without statistical testing that Group A had less amounts of 
adverse reactions.  This retrospective chart review could be the premise to test if IV 
acetaminophen reduces nausea and vomiting, pruritus, and constipation, as well as any 
other measurable adverse reactions. 
DNP Essentials Summary of Application 
Essential IV focused on technology improving patient care.  Electronic data bases 
were needed to search for peer-reviewed journals in order to investigate whether there is 
a need to treat pain postoperatively for CS mothers.  EHR and eMAR were used to 
collect data for sampling.  Essential VI expressed the importance of collaboration 
between healthcare professionals.  It is crucial for the surgeon, anesthesia providers, and 
nurses all be consistent in treating postoperative pain for the CS mothers.  Finally, 
Essential VII illustrated that the advanced practice nurse is important for improving the 
nation’s help.  Staying current on evidence-based practice encourages the best medical 
outcomes.  Using a multimodal approach for CS patients can reduce the length of stay 
and potentially decrease unwanted adverse reactions and complications. 
Conclusion 
Literature revealed that IV acetaminophen can be used to reduce the amounts of 
opioids in major orthopedic surgical procedures, spine surgery, and various other 
procedures.  However, this study did not illustrate a statistical significant reduction in the 
MME 24 or 48 hours after surgery or an increased time of first request of pain 
medication.  The study did reveal a statistical significant reduction in the LOS.  This 
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retrospective chart review gives a baseline of comparison for probable future studies, 
specifically for adverse complications or effects. 
Since there is little literature concerning the use of IV acetaminophen used to 
reduce opioid use for CS patients, more studies may be needed.  To assure that the results 
are valid or to determine if extraneous variables interfered with the results, a replication 
study may be indicated.  Different populations, more sample groups, and a controlled 
study may offer reliable and valid results. 
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APPENDIX D – Data Collection Sheet 
 
CS Data Collection Form 
 
 
AGE: _______   ASA: _______   Gestation (wks.): ______ 
 
Parity: __________  Birth:  Single or Multiple   
 
Race: ________          Co-morbidities: ___________________________________________ 
 
Duration of Labor (hrs.): ___________  Spinal: __________________________________ 
 
Anesthesia Start Time: ________________ Anesthesia Stop Time:  ____________________ 
 
Procedure Start Time:  ________________ Procedure Stop Time:  _____________________ 
 
Additional Procedures Indicated:  ____________________________________________________ 
 
Receive IV acetaminophen:  Y/N     Time of IV Acetaminophen: ____________________ 
 
IV Acetaminophen post op: ___________________________________________________________ 
 
Pain 
Medication 
       
Date/Time        
VAS/VPS        
Total 
Morphine 
Equivalents 
       
Totals        
 
PCA ordered: _______________________ 
 
Time from IV Acetaminophen to First Request Pain Medication: 
________________________________________________  
 
Adverse Reactions:  Y/N    If Yes, Explain: ____________________________________________ 
 
LOS in Hours (Admission to Discharge):   __________________________ 
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APPENDIX E – Morphine Milligram Equivalent (MME) Chart 
 
 
Opioid or Analgesic Morphine 
Milligram 
Equivalents 
(MME) 
Oxycodone/acetaminophen 7.5 
Hydrocodone/acetaminophen 5 
Ketorolac  12 
Ibuprofen  3.6 
Naproxen 4 
Roxicodone 7.5 
Fentanyl 5 
Meperidine 5 
Hydromorphone 5 
Acetaminophen/Codeine #3 4.5 
Calculated by the author using industry stated formulas. 
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APPENDIX F – Literature Matrix 
 
Author(s) Year Design Frame
work 
Sample Findings  Notes 
1. Groudine 
& Fossum 
2011 Qualitative 
study  
None 9 different 
surgical 
procedures 
including 
major 
orthopedic 
surgery, 
abdominal 
gynecologic 
surgery, 
laparoscopic 
cholecystectom
y, cesarean 
section, 
pediatric 
tonsillectomy, 
and 
laminectomy 
and discectomy 
procedures.  
Each procedure 
measured the 
efficacy of IV 
acetaminophen 
by comparing 
it with a 
placebo, with 
addition of 
steroids, 
comparing the 
synergism of 
the addition of 
a NSAID, or 
comparing it 
with IM 
meperidene. 
This study 
showed the 
safety of this 
non-opioid 
analgesic.  It 
also showed a 
reduction of 
postoperative 
pain and the 
amounts of 
opioids needed.  
It shows IV 
acetaminophen 
can be used in 
a multitude of 
operative 
procedures 
including 
pregnant and 
pediatric 
patients.  This 
study assessed 
the efficacy of 
intravenous 
acetaminophen 
and compared 
many peer-
reviewed 
studies.   
This study 
shows 
many 
types of 
studies 
with 
different 
outcomes 
and 
variables.  
While this 
can be 
seen as a 
positive 
for IV 
acetamino
phen, it 
can affect 
its 
significan
ce.  Due 
to the 
different 
studies 
and ways 
of testing 
its 
effectiven
ess, it is 
not 
consistent.  
In 
addition, 
many oral 
opioids 
contain 
acetamino
phen. 
Therefore, 
it is 
important 
to monitor 
its 
administra
tion by 
clinicians 
to prevent 
potential 
overdose. 
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2.  Wininger, 
Miller, 
Minkowitz, 
Royal, Ang, 
Breitmeyer, 
& Singla 
2010 Quantitative 
Study 
None In the U.S., 17 
sites enrolled 
244 adult 
subjects (ages 
18-80) and 
arranged the 
subjects in 4 
groups:  IV 
acetaminophen 
1000 mg [100 
mL] q6h; IV 
acetaminophen 
650 mg [65 
mL] q4h; IV 
placebo 100 
mL q6h; or IV 
placebo 65 mL 
q4h, each 
given as a 15-
minute 
infusion after 
surgery for 24 
hours. 
It was 
determined that 
both 
administrations 
of IV 
acetaminophen 
(1000mg q6h 
and 650mg 
q4h) were 
associated with 
statistically 
significant 
analgesic 
efficacy 
compared to 
the placebo 
groups.  It was 
noted that 
administrations 
of IV 
acetaminophen 
were well 
tolerated in 
both groups.  
The 
results 
from this 
study are 
consistent 
with other 
studies 
comparing 
IV 
acetamino
phen's 
effectiven
ess and 
safety 
with that 
of a 
placebo. It 
was 
looking at 
moderate 
to severe 
pain. This 
study was 
conducted 
at several 
clinical 
sites. No 
related 
hepatic SE 
were seen 
in the IV 
acetamino
phen 
groups. 
3.  Pasero & 
Stannard 
2012 Qualitative 
Case-
Illustrated 
Study  
None This study 
reviews eight 
separate cases, 
including 
laparoscopic 
surgery, major 
abdominal 
surgery, dental 
surgery, and 
orthopedic 
procedures. 
Results show 
that IV 
acetaminophen 
used in 
conjunction 
with other 
NSAIDs and 
opioids in a 
variety of 
operations, is 
effective in 
reducing pain 
and has less 
sedation when 
compared to 
opioid 
monotherapy 
alone.  It is a 
safer drug with 
very few 
interactions 
This study 
shows 
results of 
many 
surgical 
procedure
s 
including 
laparosco
pic 
procedure
s, 
abdominal 
procedure
s, 
orthopedic
, dental, 
and 
pediatric 
surgeries. 
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with other 
medications. 
4.  Marcario 
& Royal 
2012 Quantitative 
Study 
None Sixteen articles 
from 2005 
through 2010 
from 9 
countries were 
collected and 
reviewed.  
These articles 
contained 
1,464 patients.  
Twenty-two 
comparison 
studies were 
analyzed. 
This 
randomized-
controlled trial 
showed that in 
7 of 8 
comparator 
studies, IV 
acetaminophen 
had similar 
analgesic 
outcomes.  
When 
comparing IV 
acetaminophen 
to placebo, 12 
to the14 studies 
found IV 
acetaminophen 
patients had 
better analgesic 
outcomes.  
Further 
information 
showed that 10 
of the 14 
studies showed 
less opioid 
consumption 
and longer time 
to first rescue. 
This is a 
methodolo
gical RCT 
comparing 
IV 
acetamino
phen to an 
active 
comparato
r and with 
a placebo. 
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5.  De 
Oliveira, 
Castro-Alves 
& McCarthy 
2015 Quantitative 
Study 
None Eleven RCTs 
were used to 
evaluate 740 
patients, 375 
having 
received a 
single dose of 
IV 
acetaminophen 
and the 
remaining 365, 
controls, 
receiving a 
placebo. 
From the 11 
RCTs, nine 
studies 
evaluated the 
effect of 
systemic 
acetaminophen 
and noted its 
ability to help 
reduce 
postoperative 
opioid 
consumption 
when 
compared to 
the control. 
There was a 
reduction of 
opioids needed 
by patients 
when given IV 
acetaminophen 
compared to 
placebo, 
weighted mean 
difference 
(WMD) of -
9.7; 95% CI (-
13.0 to -6.4).  
Also, the study 
showed IV 
acetaminophen 
was useful in a 
reduction of 
early pain at 
rest (≤ 4 h, -1; 
(95%CI (-2.0 
to -0.2)) and 
pain at 
movement 
immediately 
postoperatively 
(24 h, -1.9; 
(95%CI (-2.8 
to -1.0)) when 
compared to 
the control.   
Researche
rs found 
that a 
single 
dose of IV 
acetamino
phen is a 
valuable 
medicatio
n to help 
diminish 
postoperat
ive pain. 
6. 
Konstantatos, 
Smith, & 
Angliss  
2012 Quantitative 
Study 
None For this study, 
145 patients 
were divided as 
follows: pre 
and 
postoperative 
placebo (n = 
50), operative 
It was 
determined 
from the 3 
groups that 
time ready for 
discharge from 
the 
postoperative 
This study 
focused 
on the 
addition 
of IV 
acetamino
phen 
administra
 51 
IV 
acetaminophen 
and 
postoperative 
PO 
acetaminophen 
(n = 49), and 
pre and 
postoperative 
PO 
acetaminophen 
(n = 48).   
care unit did 
not vary among 
the three 
groups. 
tion to 
determine 
if the 
medicatio
n helped 
reduce 
discharge 
times in 
ambulator
y surgery 
centers.   
7.  Wininger, 
Miller, 
Minkowitz 
Royal, Ang, 
Breitmeyer, 
& Singla 
2010 Quantitative 
Study 
None For this study, 
244 abdominal 
laparoscopic 
surgery 
patients were 
placed into 
four groups 
randomly: (a) 
IV 
acetaminophen 
1 gm in 100 
mL every 6 
hours, (b) IV 
acetaminophen 
650 mg in 65 
mL every 4 
hours, (c) 100 
mL of IV 
placebo every 
6 hours, and 
(d) 100 mL IV 
placebo every 
4 hours.  
The results 
showed that 
both IV 
acetaminophen 
groups 
outperformed 
the two 
placebo groups 
in terms of 
pain relief, 
reducing the 
weighted sum 
of pain 
intensity over a 
24-hour period 
(1000 mg, P < 
0.0007; 650 
mg, P < 0.019). 
This study 
is 
conducted 
in 17 
facilities 
in the US.  
Laparosco
pic 
surgery 
patients 
were 
randomly 
placed 
into four 
groups to 
compare 
IV 
acetamino
phen to 
placebo.  
These 
medicatio
ns were 
time 
scheduled 
and were 
given 24 
hours after 
surgery. 
8.  Moon, 
Lee, Lee, & 
Moon 
2011 Quantitative 
Study 
None For this 
study,76 
women who 
elected to have 
abdominal 
hysterectomies 
were divided 
into two 
groups. Group 
C, the control 
group and 
Group A, those 
who received 
 The results 
showed less 
need for 
opioids in 
Group A 
compared to 
group C (P = 
0.013)  
This study 
was a 
randomize
d, double-
blinded 
and 
placebo-
controlled, 
and was 
designed 
to learn 
whether 
IV 
 52 
IV 
acetaminophen
. 
acetamino
phen 
administer
ed prior to 
surgery 
would 
decrease 
pain 
scores, 
lessen the 
need for 
opioids, 
and 
reduce 
side 
effects. 
9.  Smith & 
Hoefling 
2014 Quantitative 
Study 
None This study 
showed the 
results of 68 
patients who 
underwent 
spinal surgery 
with anterior 
and posterior 
approaches.  
Half received 
IV 
acetaminophen 
and the other 
half was the 
control group. 
Results 
indicated that 
here was a 
decreased need 
for opioids 
(11.3 mg 
morphine 
equivalent 
[ME]) in the 
group that 
received IV 
acetaminophen 
compared to 
the control 
group (20.6 
ME).  Both 
groups were 
similar when it 
came to visual 
analog pain 
scores (VAS) 
pain scores, 
and needing 
post-surgery 
anti-emetics 
and laxatives  
An IV 
acetamino
phen 
group 
used 
significant
ly less 
opioids (p 
= 0.015) 
compared 
to the 
control 
group in a 
retrospecti
ve 
analysis 
for spinal 
surgery. 
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10.  Singla, 
Hale, Davis, 
Bekker, 
Gimbel, Jahr, 
Royal, Ang, 
& Viscusi 
2014 Quantitative 
Study 
None This was a 
double -study 
and it reviewed 
130 
participants 
with similar 
demographics 
to determine 
efficacy and 
safety of a 
single-dose IV 
acetaminophen 
for patients 
who underwent 
THAs. 
IV 
acetaminophen 
when 
compared to 
placebo, shows 
a higher mean 
pain intensity 
difference 
(PID) with 
significant 
(P<0.5) 
differences in 
treatment arms. 
  Two 
double-
blind, 
parallel-
group, 
multicente
r, 
randomize
d, 
placebo-
controlled 
clinical 
trials were 
conducted 
on 130 
participant
s with 
similar 
demograp
hics to 
determine 
efficacy 
and safety 
of a 
single-
dose IV 
acetamino
phen for 
patients 
who 
underwent 
THAs.   
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11.  Kamath 
& Lasrado 
2014 Quantitative 
Study 
None This study was 
a randomized 
parallel-group 
controlled trial.  
It compared the 
postoperative 
use of 1gm of 
IV 
acetaminophen 
or 2 gm IV 
butophanol for 
postoperative 
analgesia for 
cesarean 
section and 
other 
gynecological 
procedures.  
Tramadol was 
used as a recue 
medication for 
breakthrough 
pain. 
Either IV 
acetaminophen 
or IV 
butophanol 
was given 
postoperatively
.  Pain intensity 
was measured 
with the VAS 
scores between 
the two groups 
at multiple 
time intervals 
for a 24-hour 
time period.  
Results showed 
that the 
butorphanol 
group had 
better pain 
rating within 
the first two 
hours but IV 
acetaminophen 
resulted in 
lower pain 
scores after six 
hours after 
surgical 
procedure.  
Within the 24-
hour time 
period, the 
VAS scores 
were 
dramatically 
lower in the IV 
acetaminophen 
group (p = 
0.02) when 
compared to 
the 
butorphanol 
group. 
IV 
acetamino
phen was 
an 
effective 
and safe 
analgesic, 
and that it 
provided 
better pain 
control-
with fewer 
side 
effects-for 
the 
members 
of Group 
A than 
butorphan
ol 
provided 
for Group 
B (p = 
0.02). 
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12.  Paech, 
McDonnell, 
Sinha, Baber, 
& Nathan 
2014 Quantitative 
Study 
None This was a 
randomized, 
double blind, 
double-
dummy, 
parallel group 
placebo-
controlled 
clinical trial for 
patients having 
cesarean 
section with 
neuraxial 
anesthesia 
along with 
patient 
controlled 
epidural with 
pethidine.  
Patients were 
divided into 
three groups; 
control group 
who had 
placebo (Group 
C), those who 
received 40 mg 
of IV 
parecoxib and 
400 mg of PO 
celecoxib at 12 
hours (Group 
PC), 2 gm IV 
acetaminophen 
followed by 1 
gm of the oral 
administration 
(Group PA), 
and the last 
two groups 
combined 
(Group PCPA).  
The authors 
wanted to 
know if there 
was a decrease 
in the use of 
the patient 
controlled 
pethidine 
epidural 
infusion and 
postoperative 
pain for 111 
women: Group 
C (n = 23), 
Group PC (n = 
30), Group PA 
(n = 32), and 
Group PCPA 
(n = 26).  A 
difference was 
not shown 
between the 
four groups 
regarding 
pethidine 
consumption (p 
= 0.84).  Pain 
scores did not 
differ between 
the groups but 
the authors 
show that the 
request for 
tramadol was 
less in Group 
PCPA 
(incidence of 
23% (p = 
0.004) 
compared to 
48%, 70%, and 
58% for Group 
C, Group PC, 
and Group 
PA). 
The 
dynamic 
pain 
scores, as 
measured 
by the 
verbal 
numerical 
rating 
score, 
were not 
different 
in the 
groups, 
but the 
need for 
PO 
tramadol 
was least 
needed in 
the PCPA 
group 
(incidence 
23% 
versus 
48%, 70% 
and 58% 
in groups 
C, PC, 
and PA 
respective
ly, P = 
0.004).   
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13.  Darvish, 
Ardestani, 
Shali, & Tajik 
2013 Quantitative 
Study 
None For this study, 
120 subjects 
who had 
elective 
cesarean 
sections were 
randomly 
selected to 
show whether 
postoperative 
pain was 
controlled 
more 
effectively for 
those who 
received a 
diclofenac 
suppository 
postoperatively 
along with 1 
gm of IV 
acetaminophen 
(Group A) or 
those who 
received a 
bolus of IV 
meperidine 20 
mg (Group B) 
postoperatively
.  Meperidine 
was used for 
breakthrough 
pain and these 
results were 
compared. 
Postoperative 
pain was less 
in Group A 
(23.3%) 
compared to 
Group B 
(38.3%), (p = 
0.009).  Six 
hours after 
surgery Group 
A experienced 
less pain than 
Group B, 
16.7% and 
38.7% 
respectively (p 
= 0.010).  Pain 
was shown to 
be less 12 after 
surgery for 
Group A, p = 
0.002.  
Meperidine 
used for 
breakthrough 
pain was the 
same for both 
groups 
postoperatively 
(p > 0.5).  The 
addition of 
meperidine 
was less six 
hours 
postoperatively 
for Group A 
(6.7%) 
compared to 
Group B 
(26.7%), p = 
0.013.  After 
12 hours, 
Group A need 
no additional 
Meperidine 
compared to 
Group B, 
which received 
16.7% (p = 
0.004). 
The 
multimod
al 
combinati
on of 
diclofenac 
and IV 
acetamino
phen was 
a better 
postoperat
ive pain 
control 
method 
when 
compared 
to 
meperidin
e alone. 
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